AXL-IN-13 is a potent and orally active AXL inhibitor with an IC50 of 1.6 nM and a Kd of 0.26 nM. It exhibits anticancer activity, reverses TGF-beta1-induced epithelial-mesenchymal transition (EMT), and inhibits cancer cell migration and invasion.
Molecular Weight:
632.72
Purity:
99.95%
CAS Number:
[2376928-82-2]
Formula:
C34H41FN6O5
Target:
FLT|||TAM Receptor|||TGF-beta/Smad|||PDGFR
T73300
* VAT and and shipping costs not included. Errors and price changes excepted